Semaglutide can have a positive effect on fatty liver
In obese mice, semaglutide was found to reduce intramuscular fat accumulation and body weight, stimulate protein synthesis in muscle, and promote an increase in the relative proportion of SM
Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while tirzepatide has FDA approval and proven efficacy and safety history
If patients are not consuming enough calcium, vitamin D, and other bone-supporting nutrients, the risk of osteopenia or osteoporosis could increase over time
What started as a glucose-control challenge is now driving innovation across: Obesity Medicine Cardiovascular Care Kidney Disease AI-Powered Healthcare Precision Medicine A few trends reshaping the landscape: Diabetes is projected to affect 783 million people by 2045